Search results
Insurer Humana pulls 2025 profit forecast on disappointing Medicare rates By Reuters
Investing.com· 3 days agoThe company, which heavily depends on government-backed insurance such as Medicare Advantage (MA),...
Humana beats first-quarter profit estimates on strength in Medicare business
WHTC 1450 Holland· 3 days ago(Reuters) -Humana beat first-quarter profit expectations on Wednesday, helped by strength in its...
Decoding Humana Inc (HUM): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoStrengths Market Leadership in Medicare Advantage: Humana Inc (NYSE:HUM) has cemented its position as a market leader in the Medicare ...
Humana reports big profit beat, predicts growth in Medicare Advantage membership
Market Watch· 3 days agoThe company said the big earnings beat was mostly driven by lower-than-planned administrative...
Humana Inc. (HUM) Quarterly Report: What Does It Reveal About Their Sector Performance
ETF DAILY NEWS· 2 days agoHumana Inc. has seen steady growth in premiums revenue driven by Medicare premiums and membership. Costs have decreased, resulting in a lower operating ...
Humana Inc (HUM) Reports Mixed Q1 2024 Results; Revises Full-Year EPS Guidance
GuruFocus.com via Yahoo Finance· 3 days agoDespite the challenges, Humana reported significant strategic gains, particularly in its Medicare...
Humana stock gains after Q1 beat (NYSE:HUM)
Seeking Alpha· 3 days agoHumana (HUM) stock rose after the company reported better-than-expected Q1 2024 financials while keeping its full-year outlook unchanged. Read more here.
Decoding Humana Inc (HUM): A Strategic SWOT Insight
Guru Focus· 2 days agoHumana Inc (HUM) showcases robust revenue growth amidst challenging market conditions.Strategic focus on Medicare Advantage and healthcare services positions H
Humana beats first-quarter profit estimates on strength in Medicare business
Reuters· 3 days agoHumana beat first-quarter profit expectations on Wednesday, helped by strength in its...
Humana Shares Dip After 2025 Guidance is Pulled
The Wall Street Journal· 3 days agoThe company yanked its guidance for 2025, leaving investors worried about the impact of lower-than-expected federal rates for its core Medicare Advantage...
